Antibiotic-Resistant Organisms (AROs)

• Strengthening Governance of the Antimicrobial Resistance Response Across One Health in Canada.
  • Volume I: Final Report -Volume II: Supplemental Documents 
  • Volume I: Rapport final -Volume II: Documents supplémentaires  
• Antibiotic/Antimicrobial Resistance (CDC)
• Antimicrobial Resistance (NIAID)
• Antimicrobial Resistance (Pan American Health Organization)
• Antimicrobial Resistance Fact Sheet (NIAID)
• Antimicrobial Resistance in Long-Term Care Facilities (position paper from SHEA)
• Antimicrobial Use in Long-Term Care Facilities (position paper from SHEA)
• Canadian Agency for Drugs & Technologies in Health (CADTH) (summaries of reviews related to Infectious Diseases)
• Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS)
• Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 (CMI 2015;21: 553-559)
• Controlling Antimicrobial Resistance: An Integrated Action Plan for Canadians (PHAC and CIDS)
• Antimicrobial Resistance - A Shared Responsibility (PHAC)
• Do Bugs Need Drugs?
• European Antimicrobial Resistance Surveillance System (EARSS)
• National Antimicrobial Resistance Monitoring System (NARMS)(FDA)
• Northern Antibiotic Resistance Partnership (NARP)
• One Health Initiative (OHI) (Uniting human and veterinary medicine)
• Safer Healthcare Now! -A New Approach to Controlling Superbugs (NACS) Getting Started Kit
• Resistance Maps (Centre for Disease Dynamics, Economics and Policy)
• Universal Screening for Antibiotic-Resistant Organisms: A Review of the Clinical and Cost-Effectiveness (CADTH)
• WHO Global Strategy for Containment of Antimicrobial Resistance  
• Antimicrobial Resistance Information Bank (WHO)
• The WHO Policy Package to Combat Antimicrobial Resistance
• ​Canadian Antimicrobial Resistance Surveillance System Report 2016 (PHAC) / Système canadien de surveillance de la résistance aux antimicrobiens - Rapport de 2016 (ASPC)
• Rise on Antibiotic-Resistant Superbug Infographic -University of San Francisco School of Nursing and Health Professionals
• How Bacteria Build Resistance -George Washington University

• IPAC Canada Resources:
• House of Commons Standing Committee on Health Study on Antimicrobial Resistance in Canada
• President's Message [CJIC 2014, Vol. 29 No. 2]
• Position Statement: Antibiotic Use in Animal Husbandry
• Antibiotic Awareness (AMMI Canada)
• Antibiotic Awareness Week Toolkit / Trousse pour la Semaine de sensibilisation aux antibiotiques (PHAC)
• Antibiotic Awareness Week (NCCID)
• Alliance for the Prudent Use of Antibiotics (APUA)
• Antimicrobial Stewardship Program (Ontario)
• Antibiotic Stewardship in Human Medicine (IDSA)
• Core Elements of an Antibiotic Stewardship Program (CDC)
• Antimicrobial Resistance Solutions Initiative (CDC)
• Be Antibiotics Aware Stakeholder Toolkit (CDC)
• AntibioticWise video

• Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings (PIDAC 2013)
• Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci (position paper from SHEA/APIC)
• Methicillin-resistant Staphylococcus aureus (MRSA) (CDC)
• Safer Healthcare Now! ARO/MRSA Intervention: ARO/MRSA Getting Started Kit
• Methicillin-Resistant Staphylococcus aureus (MRSA) Screening and Discontinuation of Precautions in Hospitals: Clinical Effectiveness and Guidelines (CADTH)
• Polymerase Chain Reaction Tests for Methicillin-Resistant Staphylococcus aureus in Hospitalized Patients: Clinical and Cost-Effectiveness Analyses (CADTH)

• Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings (PIDAC 2013)
• Review of Literature for Evidence-based Best Practices for VRE Control (PIDAC)
• Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci (position paper from SHEA/APIC)
• Management of Multidrug-Resistant Organisms In Healthcare Settings, (CDC)
• SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-resistant Strains of Staphylococcus aureus and Enterococcus
• Vancomycin-resistant Enterococci (VRE) (CDC)
• Vancomycin resistant Enterococci : prevention and control measures for long term care facilities - Quebec INSPQ

• Recommended practices for the prevention of endoscopy-related infections (PHAC 2016)
  Pratiques recommandées pour la prévention d'infections liées à  des endoscopies (ASPC 2016)
• Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings (PIDAC)
• Best Practices in IPAC Related to Gram-Negative Resistance (Toolkit from CHICA/APIC/ICNA)
• Carbapenem-Producing Enterobacteriaceae (CPE) Resources
• Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings (PIDAC 2013)
• Infection Prevention and Control Measures for Healthcare Workers in All Healthcare Settings - Carbapenem-resistant Gram-negative Bacilli (PHAC 2010)
• Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase- Producing Enterobacteriaceae in Acute Care Facilities (CDC 2009)
• Public Health update of Carbapenem-Resistant Enterobacteriaceae (CRE) producing metallo-beta-lactamases (NDM, VIM, IMP) in the U.S. reported to CDC\CRE Toolkit - Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) (CDC 2012
• Detection, Treatment and Prevention of Carbapenemase-Producing Enterobacteriaceae: Recommendations from an International Working Group (J Chemotherapy 2013)

NDM-1 Resources

• Lancet Infectious Diseases:
• Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (Kumarasamy, 2010)
• The latest threat in the war on antimicrobial resistance (Pitout, 2010)
• Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern (Pitout, 2008)
• JAPI: "New Delhi Metallo-b lactamase (NDM-1) in Enterobacteriaceae: Treatment options with Carbapenems Compromised"
• U.S.: "Detection of Enterobacteriaceae Isolates Carrying Metallo-Beta-Lactamase -- United States, 2010"

• C.difficile Fact Sheet (PHAC)
• Annex C: Testing, Surveillance and Management of Clostridium difficile in All Health Care Settings (PIDAC 2013)
• Clostridium difficile Infection - Infection Prevention and Control Guidance for Management in Long-term Care Facilities (PHAC 2013)
• Clostridium difficile Infection - Infection Prevention and Control Guidance for Management in Acute Care Settings (PHAC 2013)
• Guide to Preventing Clostridium difficile Infections (APIC 2013)
• Clostridium difficile in paediatric populations (CPS 2018)

• Interim Guide for Infection Prevention and Control of Candida auris (PIDAC)
• Candida auris interim guidance document (PHAC) 
• Candida auris (CDC)
• WHO fungal priority pathogens list to guide research, development and public health action
• What health care providers need to know about Candida auris (CCDR-PHAC)
• Effectiveness of disinfectants against Candida auris and other Candida species (Abstract)
• First reported case of multidrug-resistant Candida auris in Canada (CCDR-PHAC)
• Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020
• Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021